An Investigator Initiated Phase II Clinical Trial of Tamibarotene (AM80G) for Chronic Graft-Versus-Host Disease
Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
doi 10.4044/joma.127.133
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2015
Authors
Publisher
Okayama Medical Association